These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2690093)

  • 1. Double-blind study with phosphatidylserine (PS) in parkinsonian patients with senile dementia of Alzheimer's type (SDAT).
    Fünfgeld EW; Baggen M; Nedwidek P; Richstein B; Mistlberger G
    Prog Clin Biol Res; 1989; 317():1235-46. PubMed ID: 2690093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A natural and broad spectrum nootropic substance for treatment of SDAT--the Ginkgo biloba extract.
    Fünfgeld EW
    Prog Clin Biol Res; 1989; 317():1247-60. PubMed ID: 2602410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative EEG in patients with presenile and senile dementia of the Alzheimer type.
    Miyauchi T; Hagimoto H; Ishii M; Endo S; Tanaka K; Kajiwara S; Endo K; Kajiwara A; Kosaka K
    Acta Neurol Scand; 1994 Jan; 89(1):56-64. PubMed ID: 8178630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.
    Alvarez XA; Pichel V; Pérez P; Laredo M; Corzo D; Zas R; Fernández-Novoa L; Sempere JM; Díaz J; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):585-94. PubMed ID: 11196347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of phosphatidylserine in Alzheimer's disease.
    Crook T; Petrie W; Wells C; Massari DC
    Psychopharmacol Bull; 1992; 28(1):61-6. PubMed ID: 1609044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylserine in the treatment of Alzheimer's disease: results of a multicenter study.
    Amaducci L
    Psychopharmacol Bull; 1988; 24(1):130-4. PubMed ID: 3290936
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EEG changes in senile dementia of the Alzheimer type].
    Logar C; Grabmair W; Schneider G; Lechner H
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1987 Dec; 18(4):214-7. PubMed ID: 3123199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computerised brain electrical activity findings of parkinson patients suffering from hyperkinetic side effects (hypersensitive dopamine syndrome) and a review of possible sources.
    Fünfgeld EW
    J Neural Transm Suppl; 1995; 46():351-65. PubMed ID: 8821071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylserine in the treatment of clinically diagnosed Alzheimer's disease. The SMID Group.
    J Neural Transm Suppl; 1987; 24():287-92. PubMed ID: 3479526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG mapping and psychopharmacological studies with denbufylline in SDAT and MID.
    Saletu B; Anderer P; Fischhof PK; Lorenz H; Barousch R; Böhmer F
    Biol Psychiatry; 1992 Oct; 32(8):668-81. PubMed ID: 1457622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebral mapping in patients with dementia of Alzheimer's type].
    Almárcegui C; Pascual-Millán LF; Lorente-Lasala S; Bertol-Alegre V; Valdizán-Usón JR
    Rev Neurol; 1997 Mar; 25(139):448-51. PubMed ID: 9147784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [EEG background activity in patients with dementia of the Alzheimer type--with special reference to analysis by t-statistic significance probability mapping (SPM) in Alzheimer's disease and senile dementia].
    Miyauchi T; Hagimoto H; Saito T; Endo K; Ishii M; Yamaguchi T; Kajiwara A; Matsushita M
    Seishin Shinkeigaku Zasshi; 1989; 91(4):244-59. PubMed ID: 2798586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease. A critical review.
    Gottfries CG
    Compr Gerontol C; 1988 Dec; 2(1):47-62. PubMed ID: 3076510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain electrical activity mapping in different stages of SDAT.
    Fuenfgeld EW
    Psychiatry Res; 1989 Sep; 29(3):411-2. PubMed ID: 2692057
    [No Abstract]   [Full Text] [Related]  

  • 16. [Brain performance and behavior in senile dementias of the Alzheimer type].
    Schubert H
    Wien Klin Wochenschr Suppl; 1984; 150():1-48. PubMed ID: 6592881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
    Filip V; Kolibás E
    J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
    Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
    Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of electrophysiologic studies in presenile and senile dementia].
    Quadbeck H; Brosteanu E
    Z Gerontol; 1983; 16(4):177-84. PubMed ID: 6636944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine.
    Itil TM; Eralp E; Ahmed I; Kunitz A; Itil KZ
    Psychopharmacol Bull; 1998; 34(3):391-7. PubMed ID: 9803773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.